HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tube.

Abstract
Fidaxomicin is approved for the treatment of adults with Clostridium difficile-associated diarrhea, many of whom have difficulty swallowing an intact tablet. The study objective was to evaluate the stability and recovery of crushed DIFICID(®) (fidaxomicin) 200-mg tablets dispersed in water, applesauce, or Ensure(®) brand liquid nutritional supplement, and to determine the recovery of fidaxomicin from the administration of an aqueous dispersion of a crushed DIFICID(®) tablet through a nasogastric (NG) tube. DIFICID(®) tablets were crushed and dispersed in water, applesauce, or Ensure(®). The stability and recovery of fidaxomicin were evaluated over 24 h in these vehicles. In a separate experiment, the ability to recover a full dose of fidaxomicin when administering as an aqueous dispersion through an NG tube was assessed. When DIFICID(®) tablets were crushed and dispersed in water, the active ingredient, fidaxomicin, was stable for up to 2 h at room temperature. Additionally, it was stable for up to 24 h in dispersions with applesauce or Ensure(®). Recovery of fidaxomicin after crushing and dispersing in any of the three vehicles studied ranged from 95 to 108 %, which is within the normal range of individual tablet variability. When crushed, dispersed in water, and administered through an NG tube, the average recovery of fidaxomicin was 96 %. Stability and recovery of fidaxomicin were confirmed when DIFICID(®) tablets were crushed and dispersed in water, applesauce, or Ensure(®). In addition, administration of an aqueous dispersion of a crushed tablet through an NG tube is supported by acceptable recovery of fidaxomicin.
AuthorsAnna Tousseeva, J Derek Jackson, Mark Redell, Teresa Henry, Michael Hui, Shelley Capurso, C Andrew DeRyke
JournalDrugs in R&D (Drugs R D) Vol. 14 Issue 4 Pg. 309-14 (Dec 2014) ISSN: 1179-6901 [Electronic] New Zealand
PMID25424419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminoglycosides
  • Dietary Sucrose
  • Pharmaceutical Vehicles
  • Tablets
  • Water
  • Ensure formulated food
  • Fidaxomicin
Topics
  • Aminoglycosides (chemistry, isolation & purification)
  • Dietary Sucrose
  • Drug Stability
  • Fidaxomicin
  • Food, Formulated
  • Intubation, Gastrointestinal
  • Malus
  • Pharmaceutical Vehicles (chemistry, isolation & purification)
  • Tablets
  • Water

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: